About Ameliorate Biotech
Ameliorate Biotech is a company based in Bengaluru (India) founded in 2015 by Binita Shrivastava Tunga and Rashbehari Tunga.. Ameliorate Biotech has raised $549.34 thousand across 6 funding rounds from investors including LetsVenture, Padup Ventures and DERBI Foundation. Ameliorate Biotech operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
- Headquarter Bengaluru, India
- Founders Binita Shrivastava Tunga, Rashbehari Tunga
- Stage Minicorn
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Ameliorate Biotech Private Limited
- Date of Incorporation 20 Oct, 2015
- Jurisdiction Off Kanakapura Road Tataguni, Karnataka, India
-
Annual Revenue
$37.92 K (USD)0as on Mar 31, 2023
-
Net Profit
$-57.43 K (USD)21.27as on Mar 31, 2023
-
EBITDA
$-90.68 K (USD)-30.66as on Mar 31, 2023
-
Total Equity Funding
$549.34 K (USD)
in 6 rounds
-
Latest Funding Round
$128.28 K (USD), Seed
Mar 19, 2021
-
Investors
LetsVenture
& 10 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Ameliorate Biotech
Ameliorate Biotech has successfully raised a total of $549.34K across 6 strategic funding rounds. The most recent funding activity was a Seed round of $128.28 thousand completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Seed — $128,282
- First Round First Round
- Investors Count 11
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2021 | Amount | Seed - Ameliorate Biotech | Valuation |
investors |
|
| Sep, 2020 | Amount | Seed - Ameliorate Biotech | Valuation |
investors |
|
| Jun, 2020 | Amount | Seed - Ameliorate Biotech | Valuation | LetsVenture |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Ameliorate Biotech
Ameliorate Biotech has secured backing from 11 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include LetsVenture, Padup Ventures and DERBI Foundation. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Empowering tech startups through funding and support services.
|
Founded Year | Domain | Location | |
|
Support for innovation and entrepreneurship through incubation programs in Bangalore.
|
Founded Year | Domain | Location | |
|
Sector-agnostic startups are accelerated by SINE, backed by IIT Bombay.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Ameliorate Biotech
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Ameliorate Biotech
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ameliorate Biotech Comparisons
Competitors of Ameliorate Biotech
Ameliorate Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
Dental implants and regenerative dentistry products are developed.
|
|
| domain | founded_year | HQ Location |
RNA-editing technologies are provided for precision medicine applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Ameliorate Biotech
Frequently Asked Questions about Ameliorate Biotech
When was Ameliorate Biotech founded?
Ameliorate Biotech was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Where is Ameliorate Biotech located?
Ameliorate Biotech is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Who is the current CEO of Ameliorate Biotech?
Rashbehari Tunga is the current CEO of Ameliorate Biotech. They have also founded this company.
Is Ameliorate Biotech a funded company?
Ameliorate Biotech is a funded company, having raised a total of $549.34K across 6 funding rounds to date. The company's 1st funding round was a Seed of $265.36K, raised on Aug 30, 2017.
What is the annual revenue of Ameliorate Biotech?
Annual revenue of Ameliorate Biotech is $37.92K as on Mar 31, 2023.
What does Ameliorate Biotech do?
Ameliorate Biotech was founded in 2015 in Bengaluru, India, within the biotechnology sector. Recombinant therapeutic proteins and diagnostic kits are produced using an antibiotic-free process. Biosimilar products are being developed to address treatments in oncology, autoimmune diseases, ophthalmology, and nephrology. Operations focus on advancing therapeutic solutions through recombinant technology.
Who are the top competitors of Ameliorate Biotech?
Ameliorate Biotech's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Who are Ameliorate Biotech's investors?
Ameliorate Biotech has 11 investors. Key investors include LetsVenture, Padup Ventures, DERBI Foundation, Startup Karnataka, and SINE.
What is Ameliorate Biotech's valuation?
The valuation of Ameliorate Biotech is $1.65M as of Mar 2021.